UM
Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016)
Lai, Yunfeng; Suo, Sizhuo; Wang, Ruibing; Kong, Xiangjun; Hu, Yuanjia; Tang, Daisheng; Shi, Honghao; Chen, Shengqi; Hu, Hao
2018
Source PublicationHUMAN VACCINES & IMMUNOTHERAPEUTICS
ISSN2164-5515
Volume14Issue:4Pages:847-855
AbstractThis article aims to explore the trends of monoclonal antibodies (mAbs) research and commercialization, mainly to examine the development trajectories by a contrastive exploration of successful and unsuccessful mAb. This work is based on two sets of R&D project reports, consisting of 517 discontinued mAb project reports and 64 marketed mAb project reports, from IMS Lifecycle R&D Focus. The analysis of drug development processes will provide the basic evidences of mAb technology commercialization. We examined the mAb research and commercialization from three perspectives: (1) Countries with mAb research activity; (2) Organizations participating in mAb research and development; and (3) Clusters of keywords (indication and class description) regarding mAb. The technology factor, the market factor and the abilities of participating firms to pursue commercialization were analyzed. Through data analysis, we have discovered that the research and development on mAb has reached a mature and diversified stage.
Keywordmonoclonal antibody mAb technology commercialization CiteSpace IMS
DOI10.1080/21645515.2017.1420445
URLView the original
Indexed BySCI
Language英语
WOS Research AreaBiotechnology & Applied Microbiology ; Immunology
WOS SubjectBiotechnology & Applied Microbiology ; Immunology
WOS IDWOS:000429600000017
PublisherTAYLOR & FRANCIS INC
The Source to ArticleWOS
Fulltext Access
Citation statistics
Cited Times [WOS]:1   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Recommended Citation
GB/T 7714
Lai, Yunfeng,Suo, Sizhuo,Wang, Ruibing,et al. Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016)[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS,2018,14(4):847-855.
APA Lai, Yunfeng.,Suo, Sizhuo.,Wang, Ruibing.,Kong, Xiangjun.,Hu, Yuanjia.,...&Hu, Hao.(2018).Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016).HUMAN VACCINES & IMMUNOTHERAPEUTICS,14(4),847-855.
MLA Lai, Yunfeng,et al."Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016)".HUMAN VACCINES & IMMUNOTHERAPEUTICS 14.4(2018):847-855.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Lai, Yunfeng]'s Articles
[Suo, Sizhuo]'s Articles
[Wang, Ruibing]'s Articles
Baidu academic
Similar articles in Baidu academic
[Lai, Yunfeng]'s Articles
[Suo, Sizhuo]'s Articles
[Wang, Ruibing]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Lai, Yunfeng]'s Articles
[Suo, Sizhuo]'s Articles
[Wang, Ruibing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.